Home | Background | Science | References | Purpose | Survey | Contact |
MRSA continues to evolve beyond our best and last bacteriological agents. | ||||||
---|---|---|---|---|---|---|
MRSA, Methicillin-resistant Staphylococcus aureus, one of the first bacterium to be classified as a Superbug, has evolved from the original strain of the Staphylococcus bacterium, and they can no longer kill this thing! The Penicillin family, including Methicillin, are bacterium that had been useful in killing off a wide variety of pathogens, including Staph Infections. But in the real world, the Staph has evolved, and Methicillin, grown in precisely controlled laboratories, has not. There are several reasons that traditional antibiotics are failing across the board. Common diseases are definitely getting stronger and more resilient against known Antibiotics. There is a great deal to read on this subject. This is becoming a grave concern across the Medical Industry as brand new Superbugs crop up in our hospitals and clinics across the country, and they are loosing control over existing diseases. This short video provides an overview of this serious situation. In the Medical Industry, the time needed to develop and grow more biological cures is becoming longer, and the rate of evolution for most of these Superbugs is getting faster. We as humans are quite literally loosing the evolutionary race against Microbes and Bacterium that have been evolving beyond us for Millions of years. Moreover, the wide range of Antibiotic Microbes that have been grown in laboratories over the last couple of decades have not necessarily been allowed to evolve at the same rate as other pathogens have in the real world. This is a distinct drawback in our fight against these deadly diseases. Another serious problem in using Microbes to fight off other Microbes is the microbial scale of production. In the case of Staph Infections, Methicillin was used to produce micro-liters of a metallic SOD, or SuperOxide Dismutase, which is metabolic excretion from Methicillin. That's right, Microbe Poop, which has the active metallic ingredient needed for killing off Staph infections. But unfortunately, the Staph have evolved to put up a very effective enzymatic barrier against Methicillin's "toxic poop", and now we have the Superbug, MRSA. The real problem is that medical scientists have run out of a list of Microbes that will excrete this metallic antimicrobial compound in a dismutase that is not already recognized by MRSA and other Microbes. At MetalliCure tm, we can synthesize the active metallic ingredients of that antimicrobial dismutase without all the messy cellular enzymes, and/or waiting around for it to happen on a microscopic scale. These concentrated metallic liquids are called SOMC tm, or Super-Oxygenated Metallic Compoundstm. They are effectively cover a wider range of metallic molecules than are found in many SOD's. The significant difference being, SOMC's tm are generated in large quantities as a Reagent, not grown in micro-liters as a biological secretion. MetalliCure tm has developed a new proprietary method for producing metallic based Antimicrobial SOMC's tm in mass quantities with much higher Oxygen Valence Bonding. This provides a pure solution that has a significantly longer shelf life, and uses only a small fraction of the cost in time, materials, and equipment to make compared to growing SOD Antibiotics. SOMC's tm represent, not only a "silver bullet", but a range of metallic bullets designed for immediate penetration beyond any enzymatic barriers. In other words, SOMC's tm supersede all cellular enzyme interactions and directly ionize the target cell walls. MetalliCure's tm range of SOMC's tm not only kill the target bacteria on contact, the SOMC tm can actually stop the bacteria's evolution into a more virulent form.This is the real focus in preventing these new Superbugs. Stop their evolution short with Antimicrobial Metals, not some enzyme they can grow around. It is time to take a completely different approach to destroying MRSA. MetalliCure tm has electrified one of these solutions into an Antimicrobial Metallic Liquid that already has proven results. This could be the next generation of Topical Reagents that could put a serious stop to MRSA and the other Superbug outbreaks. MetalliCure tm has also developed an effective, low cost production method for making these Super Oxygenated Metallic Compounds tm. For use in both clinical and personal settings, this counter-top appliance, "The SOMC tm Micro-Station", is no more complex than an automatic bread maker, but with a few safety differences. It can produce at least a pint of SOMC Liquid a day, which enough topical spray to last a person for more than a week. In most cases, this should be enough to mitigate the worst of their MRSA symptoms. MetalliCure tm is at the early start-up stage and is seeking the funding to put together the necessary office space and equipment to build SOMC Micro-Stations tm. in the local Bay Area, CA. You are welcome to join in the effort of helping to save 50 people from HA-MRSA this year: https://www.gofundme.com/curing-mrsa-other-superbugs Thank you for helping to save more innocent lives from the misery of MRSA. |
||||||
MetalliCure tm has the Magic Bullet that can cut past MRSA's Enzymatic Barriers. |
||||||
Home | Background | Science | References | Purpose | Survey | Contact |
As effective as Antimicrobial Metals are, the product line of SOMC's tm is strictly for use as a topical "Skin Care, Bath, & Beauty Product" only. SOMC'stm are not to be construed as any type of medication, nor should they be considered as a replacement for conventional medicines. You always have the option of consulting with your Doctor about this and any other alternative approaches you may have towards directing your own health and quality-of-life decisions. When used only as directed, these topical SOMCtm solutions are safe and effective. As always, MetalliCuretm, its employs, representatives, staff, contract suppliers, and myself cannot be held liable for any pre-existing condition(s), compounding medical issues, mis-diagnosis, adverse reactions, complications with existing prescriptions, worsening conditions, unintended death, mis-use of the solution(s), mis-handling, disassembling, reverse engineering the equipment, insurance policies, misleading information on qualifying surveys, and/or any other attempts at fraud, copy-catting, or the purchase of false, misleading products not endorsed by MetalliCuretm. |
||||||
MetalliCure,
Super-Oxygenated Metallic Compound, and SOMC are trademarks solely
owned by Greg Bender.
Future-Spark R&D, MetalliCure, SOMC, all corresponding technologies, programs, inventions, equipment & I.P. represented on all related web sites, videos, white papers, brochures, blogs, emails, and other so-marked material(s) are produced and solely owned by Greg Bender. Copyright © 2016 G.Bender, Future-Spark R&D, MetalliCuretm, SOMCtm, All Rights Reserved Worldwide. |
||||||